Triple‐negative breast cancer (TNBC) is an aggressive type of cancer, representing approximately 10% of all breast cancers1, 2 that is characterized by the absence of expression of estrogen receptors (ERs), progesterone receptors (PRs), and epidermal growth factor receptor 2 (HER‐2).3 The gene discussed is ESR1; the disease is cancer.